Detalles de la búsqueda
1.
Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue.
J Cell Biochem
; 112(4): 1206-18, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21312238
2.
Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.
Biol Blood Marrow Transplant
; 15(2): 214-22, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19167681
3.
Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.
Biol Blood Marrow Transplant
; 15(6): 730-40, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19450758
4.
Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.
Haematologica
; 94(6): 827-32, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19483157
5.
A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation.
Int J Hematol
; 86(2): 186-92, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17875536
Resultados
1 -
5
de 5
1
Próxima >
>>